# Sun Pharmaceutical Industries, Inc.: Lisdexamfetamine Dimesylate Capsule shortage update (limited availability from this maker)

**Score:** 50/100

| Field | Value |
|---|---|
| Manufacturer | Sun Pharmaceutical Industries, Inc. |
| Drug | Lisdexamfetamine Dimesylate Capsule |
| Dosage form | Capsule |
| Therapeutic category | Psychiatry |
| Status | Current |
| Stage | Shortage revised (availability or dates changed) |
| Availability | Limited availability |
| Reason | Other |
| Presentations affected | 7 |
| Package NDCs | 57664-048-88, 57664-049-88, 57664-046-88, 57664-051-88, 57664-052-88, 57664-050-88 |
| Manufacturer supply note | Estimated recovery: TBD |
| First posted | 2023-07-14 |
| Updated | 2026-10-30 |

## Why this score
- Shortage details just changed.
- Limited availability.

Source: openFDA drug shortages endpoint (U.S. Food and Drug Administration drug shortage list) (https://dps.fda.gov/drugshortages). Last refreshed: 2026-11-04T06:10:12.565Z.
From the openFDA drug shortages endpoint, which mirrors the FDA drug shortage list and can lag it by days. Availability and recovery notes are the manufacturer's own statements to FDA. Company and product level only. Verify with FDA and the manufacturer before acting.